Differential activation of adenylate cyclase by secretin and VIP receptors in the calf pancreas

Pancreas

Volumn 31, Issue 2, 2005, Pages 174-181

  Le Meuth Metzinger, Valérie ^a   Philouze Rome, Véronique ^b   Metzinger, Laurent ^c   Gespach, Christian ^d   Guilloteau, Paul ^b  

^a UNIVERSITÉ PARIS 13   (France)

^b CEMAGREF   (France)

^c UNIVERSITÉ DE RENNES 1   (France)

^d HÔPITAL SAINT ANTOINE   (France)

Author keywords

Adenylate cyclase activation; Calf digestive tract; Pancreatic secretion; Secretin receptor; Vasoactive intestinal polypeptide 2 receptor

Indexed keywords

ADENYLATE CYCLASE; SECRETIN; SECRETIN RECEPTOR; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATTLE; CONTROLLED STUDY; CROSS LINKING; ENZYME ACTIVATION; GENE; GENE EXPRESSION; LIGAND BINDING; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PANCREAS SECRETION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEC R GENE;

ADENYLATE CYCLASE; ANIMALS; BASE SEQUENCE; CATTLE; GENE EXPRESSION; MOLECULAR SEQUENCE DATA; PANCREAS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, GASTROINTESTINAL HORMONE; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE, TYPE II; RECEPTORS, VASOACTIVE INTESTINAL POLYPEPTIDE, TYPE I; SECRETIN; VASOACTIVE INTESTINAL PEPTIDE;

EID: 23044461040     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpa.0000174938.89815.e9     Document Type: Article

References (47)

1. Boden G, Essa N, Owen OE, et al. Effects of intraduodenal administration of HC1 and glucose on circulating immunoreactive secretin and insulin concentrations. J Clin Invest. 1974;53:1185-1193.
2. Titchen DA. Gastrointestinal peptide hormone distribution, release, and action in ruminants. In: Milligan LP, Grovum WL, Dobson A, eds. Control of Digestion and Metabolism in Ruminants. Englewood Cliffs, NJ: Prentice-Hall; 1986:227-248.
3. Said SI. Vasoactive intestinal peptide. A review. J Endocrinol Invest. 1986;9:191-200.
4. Miyata A, Arimura A, Dahl RR, et al. Isolation of a novel 38 residue hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochim Biophys Res Commun. 1989;164:567-574.
5. Ulrich CD, Holtmann M, Miller LJ. Secretin and vasoactive intestinal peptide receptor: members of a unique family of G protein-coupled receptors. Gastroenterology. 1998;114:382-397.
6. Fölsch UR, Creutzfeldt W. Pancreatic duct cells in rats secretory studies in response to secretin, cholecystokinin-pancreozymin, and gastrin in vivo. Gastroenterology. 1977;73:1053-1059.
7. Ulrich CD, Wood P, Hadac EM, et al. Cellular distribution of secretin receptor expression in rat pancreas. Am J Physiol. 1998;275:G1437-G1444.
8. Solomon TE, Petersen H, Elashoff J, et al. Interaction of caerulein and secretin on pancreatic size and composition in rat. Am J Physiol. 1978; 235:E174-E179.
9. Dembinski AB, Johnson LR. Stimulation of pancreatic growth by secretin, caerulein, and pentagastrin. Endocrinology. 1980;106:323-328.
10. Robberecht P, Waelbroeck M, Noyer M, et al. Characterization of secretin and vasoactive intestinal peptide receptors in rat pancreatic plasma membranes using the native peptides, secretin-(7-27) and five secretin analogues. Digestion. 1982;23:201-210.
11. Robberecht P, De Neef P, Waelbroeck M, et al. Secretin receptors in human pancreatic membranes. Pancreas. 1988;3:529-535.
12. Bissonnette BM, Collen MJ, Adachi H, et al. Receptors for vasoactive intestinal peptide and secretin on rat pancreatic acini. Am J Physiol. 1984; 246:G710-G717.
13. Susini C, Estival A, Scemama JL, et al. Studies on human pancreatic acini: action of secretagogues on amylase release and cellular cyclic AMP accumulation. Pancreas. 1986;1:124-129.
14. Zhou ZC, Gardner JD, Jensen RT. Interaction of peptides related to VIP and secretin with guinea-pig pancreatic acini. Am J Physiol. 1989;256: G283-G290.
15. Guilloteau P, Le Huerou-Luron I, Chayvialle JA, et al. Plasma and tissue levels of digestive regulatory peptides during postnatal development and weaning in the calf. Reprod Nutr Dev. 1992;32:285-296.
16. Davicco MJ, Le Faivre J, Barlet JP. The endocrine regulation of exocrine pancreas in preruminant milk-fed calves. Ann Rech Vet. 1980;11:123-132.
17. Pierzynowski SG, Zabielski R, Weström BR, et al. Development of the exocrine pancreatic function in chronically cannulated calves from the preweaning period up to early rumination. J Anim Physiol Anim Nutr. 1991;65:165-172.
18. Zabielski R, Pierzynowski SG, Podgumiak P, et al. Effects of secretin and cholecystokinin octapeptide (CCK 8) on exocrine pancreas during cold vagal blockade in calves. J Anim Physiol Anim Nutr. 1992;67:173-180.
19. Ishihara T, Nakamura S, Kaziro Y, et al. Molecular cloning and expression of a cDNA encoding the secretin receptor. EMBO J. 1991;10:1635-1641.
20. Ulrich CD, Pinon DI, Hadac EM, et al. Intrinsic photoaffinity labeling of native and recombinant rat pancreatic secretin receptors. Gastroenterology. 1993;105:1534-1543.
21. Jiang S, Kopras E, Mc Michael M, et al. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells. Cancer Res. 1997;57:1475-1480.
22. Adamou JE, Aiyar N, Van Horn S, et al. Cloning and functionnal characterization of the human vasoactive intestinal peptide (VIP)-2 receptor. Biochem Biophys Res Commun. 1995;209:385-392.
23. Reubi JC, Läderach U, Waser B, et al. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin. Cancer Res. 2000;60:3105-3112.
24. Usdin TB, Bonner TI, Mezey E. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. Endocrinology. 1994;135:2662-2680.
25. Ito T, Hou W, Katsuno T, et al. Rat and guinea-pig pancreatic acini possess both VIP1 and VIP2 receptors, which mediate enzyme secretion. Am J Physiol. 2000;278:G64-G74.
26. Le Meuth V, Farjaudon N, Bawab W, et al. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas. Am J Physiol. 1991;260:G265-G274.
27. Marino LR, Cotton CU. Immortalization of bovine pancreatic duct epithelial cells. Am J Physiol. 1996;270:G676-G683.
28. Chirgwin JM, Przybyla AE, Mac Donald RJ, et al. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979;18:5294-5299.
29. Le Huërou-Luron I, Wicker C, Guilloteau P, et al. Specific regulation of the gene expression of some pancreatic enzymes during postnatal development and weaning in the calf. Biochim Biophys Acta. 1990;1048: 257-264.
30. Chastre E, Emami S, Rosselin G, et al. Ontogenic development of vasoactive intestinal peptide receptors in rat intestinal cells and liver. Endocrinology. 1987;12:2211-2221.
31. 125I-secretin to identify and characterize high-affinity secretin receptors on pancreatic acini. Am J Physiol. 1983;245:G186-G195.
32. Svoboda M, Tastenoy M, De Neef P, et al. Molecular cloning and in vitro properties of the recombinant rabbit secretin receptor. Peptides. 1998;19: 1055-1062.
33. Holtmann MH, Hadac EM, Ulrich CD, et al. Molecular basis and species specificity of high affinity binding of vasoactive intestinal polypeptide by the rat secretin receptor. J Pharmacol Exp Ther. 1996;279:555-560.
34. Alonso RM, Rodriguez AM, Garcia LJ, et al. Comparison between the effects of VIP and the novel peptide PACAP on the exocrine pancreatic secretion of the rat. Pancreas. 1994;9:123-128.
35. Trimble ER, Bruzzone R, Biden TJ, et al. Secretin stimulates cyclic AMP and inositol trisphosphate production in rat pancreatic acinar tissue by two fully independent mechanisms. Proc Natl Acad Sci USA. 1987; 84:3146-3150.
36. Jiang S, Ulrich CD. Molecular cloning and functional expression of human pancreatic secretin receptor. Biochem Biophys Res Commun. 1995; 207:883-890.
37. Chow BKC. Molecular cloning and functional characterization of a human secretin receptor. Biochem Biophys Res Commun. 1995;212:204-211.
38. Patel DR, Kong Y, Sreedharan SP. Molecular cloning and espression of a human secretin receptor. Mol Pharmacol. 1995;47:467-473.
39. 2 receptors. Ann N Y Acad Sci. 1998;865:247-252.
40. Gespach C, Bataille D, Vauclin N, et al. Secretin receptor activity in rat gastric glands. Binding studies, cAMP generation and pharmacology. Peptides. 1986;7:155-163.
41. Haffar RM, Hocart SJ, Coy DH, et al. Reduced peptide bond pseudopeptide analogues of secretin. A new class of secretin receptor antagonist. J Biol Chem. 1991;266:316-322.
42. 2NH)4,5] secretin on pancreatic exocrine secretion in guinea pigs and rats. Am J Physiol. 1993;265: 0805-0810.
43. Wessels-Reiker M, Basiboina R, Howlett AC, et al. Vasoactive intestinal polypeptide-related peptides modulates tyrosine hydroxylase gene expression in PC 12 cells through multiple adenylate cyclase-coupled receptors. J Neurochem. 1993;60:1018-1029.
44. Toullec R, Chayvialle JA, Guilloteau P, et al. Early-life patterns of plasma gut regulatory peptide levels in calves, effects of age, weaning and feeding. Comp Biochem Physiol. 1992;102A:203-209.
45. Le Dréan G, Le Huërou-Luron I, Gestin M, et al. Pancreatic secretory response to feeding in the calf: CCK-A receptors, but not CCK-B/gastrin receptors are involved. Can J Physiol Pharmacol. 2000;78:813-819.
46. Zabielski R, Onaga T, Mineo H, et al. Local versus peripheral blood administration of cholecystokinin-8 and secretin on pancreatic secretion in calves. Exp Physiol. 1994;79:301-311.
47. Le Dréan G, Le Huërou-Luron I, Chayvialle JA, et al. Kinetics of pancreatic exocrine secretion and plasma gut regulatory peptide release in response to feeding in preruminant and ruminant calves. Comp Biochem Physiol. 1997;117A:245-255.